Synthetic Human Secretin
Sponsors
Shinichi Yachida, Shinich Yachida, Mayo Clinic, Columbia University, Elizabeth Hecht
Conditions
Abdominal PainIntraductal papillary mucinous neoplasm
IPMNIrritable Bowel SyndromePancreatic CancerPersons at high risk of pancreatic cancer
Family history of pancreatic cancer
Phase 1
Phase 3
Unknown Phase
Comparison of Secretin-enhanced Magnetic Resonance Cholangiopancreatography (S-MRCP) to Endoscopic Pancreatic Function Test (ePFT) in Diagnosing Pancreatic Exocrine Insufficiency
WithdrawnNCT01094600
Start: 2012-06-30End: 2012-06-30Updated: 2012-07-02
Secretin-Stimulated Magnetic Resonance Cholangiopancreatography (S-MRCP) in Pancreatic Patients
CompletedNCT01094561
Start: 2006-07-31End: 2015-03-31Updated: 2016-09-09
Secretin-enhanced Magnetic Resonance Cholangiopancreatography (S-MRCP) and Pancreatic Function Following Surgery
WithdrawnNCT01094535
Start: 2007-09-30End: 2012-09-30Updated: 2015-04-06
Optical and Biochemical Biomarkers in Early Pancreatic Cancer
CompletedNCT03404661
Start: 2018-01-11End: 2022-03-10Updated: 2023-06-06
A study on the grading of intraductal papillary mucinous tumor (IPMN) by esophagogastroduodenoscopy using a synthetic human secretin preparation and a specialized catheter
RecruitingJPRN-jRCTs051230154
Start: 2024-01-12Target: 400Updated: 2026-06-29
Development of a diagnostic method for pancreatic cancer by esophagogastroduodenoscopy using a synthetic human secretin preparation and a special catheter
RecruitingJPRN-jRCTs051230169
Start: 2024-01-25Target: 600Updated: 2026-06-29